69 related articles for article (PubMed ID: 24329588)
1. Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens.
Gooren L; Morgentaler A
Andrologia; 2014 Dec; 46(10):1156-60. PubMed ID: 24329588
[TBL] [Abstract][Full Text] [Related]
2. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
3. Conjectures concerning cross-sex hormone treatment of aging transsexual persons.
Gooren L; Lips P
J Sex Med; 2014 Aug; 11(8):2012-9. PubMed ID: 24775178
[TBL] [Abstract][Full Text] [Related]
4. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
[TBL] [Abstract][Full Text] [Related]
5. Effects of three different testosterone formulations in female-to-male transsexual persons.
Pelusi C; Costantino A; Martelli V; Lambertini M; Bazzocchi A; Ponti F; Battista G; Venturoli S; Meriggiola MC
J Sex Med; 2014 Dec; 11(12):3002-11. PubMed ID: 25250780
[TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges.
Deebel NA; Morin JP; Autorino R; Vince R; Grob B; Hampton LJ
Urology; 2017 Dec; 110():166-171. PubMed ID: 28882782
[TBL] [Abstract][Full Text] [Related]
7. Sex reassignment of transsexual people from a gynecologist's and urologist's perspective.
Trum HW; Hoebeke P; Gooren LJ
Acta Obstet Gynecol Scand; 2015 Jun; 94(6):563-7. PubMed ID: 25721104
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer in transgender women.
Ingham MD; Lee RJ; MacDermed D; Olumi AF
Urol Oncol; 2018 Dec; 36(12):518-525. PubMed ID: 30322726
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.
de Nie I; de Blok CJM; van der Sluis TM; Barbé E; Pigot GLS; Wiepjes CM; Nota NM; van Mello NM; Valkenburg NE; Huirne J; Gooren LJG; van Moorselaar RJA; Dreijerink KMA; den Heijer M
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3293-9. PubMed ID: 32594155
[TBL] [Abstract][Full Text] [Related]
10. Metastatic Prostate Cancer 35 Years After Sex Reassignment Surgery.
Ellent E; Matrana MR
Clin Genitourin Cancer; 2016 Apr; 14(2):e207-9. PubMed ID: 26707953
[No Abstract] [Full Text] [Related]
11. Oestrogen and anti-androgen therapy for transgender women.
Tangpricha V; den Heijer M
Lancet Diabetes Endocrinol; 2017 Apr; 5(4):291-300. PubMed ID: 27916515
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Prostate Cancer in Transgender Women Undergoing Androgen Deprivation Therapy: A Review.
Tyagi S; Tyagi S
Indian J Endocrinol Metab; 2023; 27(6):476-479. PubMed ID: 38371191
[TBL] [Abstract][Full Text] [Related]
14. Transgender Endocrinology: Evidence-Based Evolution and Expansion.
Kalra S
Indian J Endocrinol Metab; 2023; 27(6):465-466. PubMed ID: 38371179
[No Abstract] [Full Text] [Related]
15. [Psychiatric, socio-legal and perioperative aspects of vaginoplasty].
Heß J
Urologie; 2024 Jan; 63(1):51-57. PubMed ID: 38157067
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges.
Manfredi C; Ditonno F; Franco A; Bologna E; Licari LC; Arcaniolo D; Tubaro A; De Nunzio C; Antonelli A; De Sio M; Cherullo EE; Autorino R
Curr Oncol Rep; 2023 Dec; 25(12):1431-1443. PubMed ID: 37910274
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening and management in the transgender population: Review of literature and special considerations for gender affirmation surgery.
Panichella JC; Araya S; Nannapaneni S; Robinson SG; You S; Gubara SM; Gebreyesus MT; Webster T; Patel SA; Hamidian Jahromi A
World J Clin Oncol; 2023 Jul; 14(7):265-284. PubMed ID: 37583948
[TBL] [Abstract][Full Text] [Related]
18. Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Hodan R; Rodgers-Fouche L; Chittenden A; Dominguez-Valentin M; Ferriss J; Gima L; Hamnvik OR; Idos GE; Kline K; Koeller DR; Long JM; McKenna D; Muller C; Thoman M; Wintner A; Bedrick BS;
Fam Cancer; 2023 Oct; 22(4):437-448. PubMed ID: 37341816
[TBL] [Abstract][Full Text] [Related]
19. Gender-Affirming Surgery and Cancer: Considerations for Radiation Oncologists for Pelvic Radiation in Transfeminine Patients.
Smart AC; Liu KX; Domogauer JD; Rodriguez-Russo C; Jones B; Dickstein DR; Mancias JD; Shiloh RY; Wintner A; Zietman AL; Marshall DC; Dyer MA; Russo AL
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):301-311. PubMed ID: 37230432
[TBL] [Abstract][Full Text] [Related]
20. Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer.
Dickstein DR; Edwards CR; Lehrer EJ; Tarras ES; Gallitto M; Sfakianos J; Galsky MD; Stock R; Safer JD; Rosser BRS; Marshall DC
Nat Rev Urol; 2023 Jun; 20(6):332-355. PubMed ID: 37217695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
